# OnCo record npra-malaysia (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/npra-malaysia/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "npra-malaysia" ;
  schema:name "National Pharmaceutical Regulatory Agency (NPRA), Malaysia"@en ;
  schema:alternateName "NPRA"@en, "Bahagian Regulatori Farmasi Negara"@en, "Drug Control Authority"@en, "Pihak Berkuasa Kawalan Dadah"@en, "DCA Malaysia"@en ;
  schema:description "Malaysia's medicines regulator, part of the Ministry of Health. It evaluates new medicines for the Drug Control Authority in a target of 245 working days, and has shorter reliance routes for medicines already approved by named reference regulators."@en ;
  schema:url <https://onco.cc/institutions/npra-malaysia/>, <https://www.npra.gov.my> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://npra.gov.my/~npraweb/easyarticles/images/users/1153/drgd_appendices/APPENDIX-3-Guidelines-on-Registration-of-New-Drug-Products.pdf>, <https://npra.gov.my/easyarticles/images/users/1051/Direktif--Guideline-FRP-Nov-2023.pdf>, <https://npra.gov.my/index.php/en/component/content/article/225-english/1527850-new-route-under-the-facilitated-registration-pathway-frp-a-one-year-pilot-study-commencing-2-may-2026.html>, <https://doi.org/10.1007/s43441-025-00846-3>, <https://www.npra.gov.my> ;
  schema:addressCountry "MY" ;
  schema:addressLocality "Petaling Jaya" ;
  schema:latitude "3.107"^^xsd:decimal ;
  schema:longitude "101.606"^^xsd:decimal ;
  onco:institutions <https://onco.cc/institutions/ministry-of-health-malaysia/>, <https://onco.cc/institutions/mahtas-malaysia/>, <https://onco.cc/institutions/clinical-research-malaysia/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-mohd-sani-npra-approval-times-opera-tirs-2025/>, <https://onco.cc/key-papers/paper-sani-npra-new-active-substances-2017-opera-tirs-2020/> .
